Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DOW vs MRNA✓SelectedUSD · MRNADOW vs MRNA performance historyLatest closeAs of-4.03%11/20
Stock and ETF performance explorer

DOW vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-33.2%
MRNA return
+153.9%
Excess return
-187.1%
Maximum drawdown
-62.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.0%-2.2%-1.9%-4.0%
7D-12.1%-12.7%+0.6%-11.8%
30D-4.4%-20.7%+16.2%-3.9%
3M-10.7%+46.3%-57.0%-12.4%
6M-18.2%+305.2%-323.4%-28.4%
YTD+28.4%+561.2%-532.9%+1.4%
1Y+45.4%+772.1%-726.7%+9.2%
3Y-33.2%+147.0%-180.2%-48.2%
All-33.2%+153.9%-187.1%-48.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling